BLT 0.00% 2.6¢ benitec biopharma limited

Ann: SECOND PATIENT DOSED IN TT034 TRIAL, page-11

  1. 418 Posts.
    lightbulb Created with Sketch. 138
    To paraphrase Peter French from the webcast.
    "there are numerous methods available to overcome nABs if they arise but at this early stage to establish safety we don't want to overcomplicate the trial"
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.